» Articles » PMID: 35194311

Worrisome Trends of ST-elevation Myocardial Infarction During the Covid-19 Pandemic: Data from Portuguese Centers

Abstract

Introduction: During the Covid-19 pandemic there has been a general belief that hospital admissions for non-infectious causes, especially cardiovascular diseases, have fallen.

Objectives: To assess the impact of the pandemic on admissions for ST-elevation myocardial infarction (STEMI) during the first pandemic wave.

Methods: We performed a multicenter retrospective analysis of consecutive patients presenting with STEMI in two Portuguese hospital centers in two sequential periods - P1 (March 1 to April 30) and P2 (May 1 to June 30). Patient's clinical data and hospital outcomes were compared between the years 2017 to 2019 and 2020 for both periods.

Results: During P1 in 2020, a reduction in the number of STEMI patients was observed in comparison with previous years (26.0±4.2 vs. 16.5±4.9 cases per month; p=0.033), as well as an increase in the number of mechanical complications (0.0% vs. 3.0%; p=0.029). Percutaneous coronary interventions in the setting of failed thrombolysis were more frequent (1.9% vs. 9.1%; p=0.033). An overall trend for longer delays in key timings of STEMI care bundles was noted. Mortality was higher during P1 compared to previous years (1.9% vs. 12.1%; p=0.005).

Conclusions: During the first Covid-19 wave fewer patients presented with STEMI at the catheterization laboratory for percutaneous coronary intervention. These patients presented more mechanical complications and higher mortality.

Citing Articles

The Best Articles of 2022 in the Arquivos Brasileiros de Cardiologia and Revista Portuguesa de Cardiologia.

Oliveira G, Fontes-Carvalho R, Cardim N, Rochitte C Arq Bras Cardiol. 2023; 120(7):e20230342.

PMID: 37556657 PMC: 10382155. DOI: 10.36660/abc.20230342.


ST-elevation myocardial infarction in the Covid-19 pandemic: A step backward in a success story.

Cyrne Carvalho H Rev Port Cardiol. 2022; 41(6):473-474.

PMID: 35194313 PMC: 8853745. DOI: 10.1016/j.repc.2022.02.003.

References
1.
Rodriguez-Leor O, Cid-Alvarez B, de Prado A, Rossello X, Serrador A, Lopez-Palop R . Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience. Rev Esp Cardiol (Engl Ed). 2020; 73(12):994-1002. PMC: 7834732. DOI: 10.1016/j.rec.2020.08.002. View

2.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

3.
Thygesen K, Alpert J, Jaffe A, Chaitman B, Bax J, Morrow D . Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2018; 40(3):237-269. DOI: 10.1093/eurheartj/ehy462. View

4.
Teles R, Pires-Morais G, da Silva P, Ferreira R, De Sousa Almeida M, Seixo F . Portugal: coronary and structural heart interventions from 2010 to 2015. EuroIntervention. 2017; 13(Z):Z55-Z58. DOI: 10.4244/EIJ-D-16-00831. View

5.
Solomon M, McNulty E, Rana J, Leong T, Lee C, Sung S . The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction. N Engl J Med. 2020; 383(7):691-693. DOI: 10.1056/NEJMc2015630. View